We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
The European Commission has ordered Ireland to recoup 13 billion euro from tech giant Apple over a sweetheart tax deal.
About 6,500 migrants have been saved off the Libyan coast in one of the largest rescue missions this year.
Amy Sharp, 18, posted the request on a Facebook post appealing for her whereabouts after she escaped from a police station.